» Articles » PMID: 10479390

Isolation and Characterization of Two Human Monoclonal Anti-phospholipid IgG from Patients with Autoimmune Disease

Overview
Journal J Autoimmun
Date 1999 Sep 10
PMID 10479390
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The antigenic specificity of anti-phospholipid antibodies (APA) is a matter of intensive investigation. To further characterize these antibodies, we attempted to isolate human monoclonal APA. B-cells of patients with at least one positive test for antibodies against cardiolipin, phosphatidylserine, beta2-glycoprotein I (beta2-GPI) or the lupus anti-coagulant were immortalized by transformation with Epstein-Barr virus and screened for production of specific IgG. Positive pools were fused with a heteromyeloma cell line and APA-secreting clones were isolated by standard procedures. Two monoclonal APA, HL-5B from a 51-year-old man with primary anti-phospholipid syndrome and recurrent cerebral microinfarctions, and RR-7F from a 48-year-old women with systemic lupus erythematosus but no evidence for thrombotic events were obtained. HL-5B is of the IgG2 subtype with lambda light chains, while RR-7F is IgG2 with kappa light chains. Both monoclonals show reactivity against cardiolipin and phosphatidylserine but lack reactivity against beta2-GPI or lupus anti-coagulant activity. To yield the same OD in the cardiolipin and phosphatidylserine ELISAs RR-7F must be used in an approximately 10-fold higher concentration than HL-5B, indicating a lower affinity towards these antigens. Interestingly, both mAPA can bind to cardiolipin in the absence of beta2-GPI. They do not cross-react with dsDNA but show reactivity against oxidized low-density lipoproteins. Analysis of the heavy chain mRNA of HL-5B and RR-7F showed that both are members of the VH3 family. While HL-5B shows extensive somatic mutations in the CDR1 and 2 regions, indicating that it was derived by a T cell-dependent antigen driven process, RR-7F is apparently germline encoded. The two monoclonal APA can be used as tools in further structural and functional analyses.

Citing Articles

Improving diagnosis in patients with obstetric antiphospholipid syndrome through the evaluation of non-criteria antibodies.

Alvarez D, Winter H, Velasquez Franco C, Castellanos Gutierrez A, Banos N, Markert U Clin Transl Immunology. 2024; 13(12):e70021.

PMID: 39678173 PMC: 11638733. DOI: 10.1002/cti2.70021.


Lipid presentation by the protein C receptor links coagulation with autoimmunity.

Muller-Calleja N, Hollerbach A, Royce J, Ritter S, Pedrosa D, Madhusudhan T Science. 2021; 371(6534).

PMID: 33707237 PMC: 9014225. DOI: 10.1126/science.abc0956.


Antiphospholipid Antibodies: Their Origin and Development.

Lackner K, Muller-Calleja N Antibodies (Basel). 2019; 5(2).

PMID: 31557996 PMC: 6698834. DOI: 10.3390/antib5020015.


Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies.

Muller-Calleja N, Ritter S, Hollerbach A, Falter T, Lackner K, Ruf W Blood Adv. 2018; 2(9):979-986.

PMID: 29716893 PMC: 5942002. DOI: 10.1182/bloodadvances.2018017095.


Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers.

Roggenbuck D, Borghi M, Somma V, Buttner T, Schierack P, Hanack K Arthritis Res Ther. 2016; 18(1):111.

PMID: 27209064 PMC: 4875598. DOI: 10.1186/s13075-016-1018-x.